FdaApplication
ANDA 210160
Identifiers
- fda_app_no: ANDA210160
Properties
| Property | Value |
|---|---|
| applicant_name | TORRENT PHARMS LTD |
| application_type | ANDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ALOGLIPTIN; METFORMIN HYDROCHLORIDE | ALOGLIPTIN; METFORMIN HYDROCHLORIDE | EQ 12.5MG BASE;1GM | TABLET;ORAL |
| ALOGLIPTIN; METFORMIN HYDROCHLORIDE | ALOGLIPTIN; METFORMIN HYDROCHLORIDE | EQ 12.5MG BASE;500MG | TABLET;ORAL |
2 products